Methods for treating Parkinson's disease

Patent Number: 9387212

Patent Date: 2016-07-12

Patent type: utility

The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A<sub>2A</sub>) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.

Inventors

First Name	Last Name	City	State	Country
Bernard	Christophe	-	-	-
Dieter	Scheller	-	-	-
Anne	Michel	-	-	-
Patrick	Downey	-	-	-
Florian	Montel	-	-	-

IPCs

Section	Class	Sub Class	Group	Sub Group
A	61	K	31	5377
A	61	K	31	195
A	61	K	31	198
A	61	K	31	445
A	61	K	31	451
A	61	K	31	495
A	61	K	31	497
A	61	K	31	501
A	61	K	31	506
A	61	K	31	519
A	61	K	31	52
A	61	K	31	423
A	61	K	31	5415
A	61	K	45	06
A	61	K	31	454

Assignee

Organization	First Name	Last Name	City	State	Country
UCB Biopharma SPRL	-	-	-	-	-